Industry payments · Boston Scientific · Nevada · 2025

What did Boston Scientific pay clinicians in Nevada?

In 2025, Boston Scientific reported $223K in general payments to 882 Nevada clinicians across 3,395 payments, per CMS Open Payments data (excluding one-time buyouts). The typical (median) clinician on the list received $52. Below: where the money went, and who it went to by specialty and city. No clinician is named on this page; the ranked, named list is what the app is for.

$223K
General payments, excl. buyouts (2025)
882
Nevada clinicians paid
$52
Median clinician total
↓ 9%
Dollars vs 2024
The breakdown

Where the money went.

General payments by category, and the products named on them. A payment is a disclosed relationship, not evidence a clinician uses any product.

Payment mix in Nevada

Food & beverage · 879 clinicians$134K
Travel & lodging · 28 clinicians$28K
Grant · 2 clinicians$25K
Speaker / services · 3 clinicians$21K
Consulting · 6 clinicians$14K

Top products named on payments

General - Therapies$42K
Intracept$24K
General - Pain Management$23K
TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$14K
FARAPULSE$11K
Axonics$11K
WATCHMAN FLX$11K
Vitalyst$9K

Product dollars span all payment types, and a payment naming several products counts toward each, so these rows don't sum to the total above.

The names behind these 882 clinicians are in the same public record. Prospect 811 puts them one search away: every Nevada clinician Boston Scientific paid, ranked by dollars, cross-linked to what each one actually bills Medicare, with specialty and phone number.

See who they paid
Who gets paid

The specialties and cities.

Top specialties paid

Family Nurse Practitioner87 clinicians
Internal Medicine Physician78 clinicians
Cardiovascular Disease Physician72 clinicians
Anesthesiology Physician52 clinicians
Physician Assistant51 clinicians

Where the paid clinicians are

Las Vegas543 clinicians
Reno144 clinicians
Henderson93 clinicians
Carson City26 clinicians
North Las Vegas22 clinicians
Where these numbers come from. Everything on this page is computed from CMS's public Open Payments (Sunshine Act) data for program year 2025. Federal law requires manufacturers and group purchasing organizations to report payments and transfers of value to physicians and other covered clinicians; CMS publishes the records each year. A reported payment is a disclosed financial relationship required by law. It is not evidence of anything improper, and it says nothing about whether a clinician uses, prefers, or prescribes any product. Totals are general payments only and exclude acquisition buyouts and debt forgiveness (one-time events, not working relationships). Research dollars are shown separately as associated funding: money tied to a study on which a clinician is named as recipient or principal investigator. It funds the study, not the person. Product rows count a payment toward every product named on it, across all payment types, so product rows do not add up to the total. Boston Scientific figures combine the 22 corporate entities that report under it, normalized so the whole company shows up as one. Clinicians whose federal enrollment record no longer lists a US practice state are not in state rollups. Prospect 811 organizes public data; it doesn't add to or alter it. Not affiliated with or endorsed by CMS. Full detail on the data page.

Industry relationships are public record. Your edge is knowing them.

Prospect 811 links Open Payments to Medicare billing for every clinician in your territory: who Boston Scientific pays, what those clinicians bill, and who takes no industry money at all. $79/month, no contract, 14-day refund.

Start prospecting
Sign in with Google or a magic link · or grab the free DIY guide first.